| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3d855bca0476ee3f69bb6b95acb10c77
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fe6cdce3549333495fabaa8e02a80bd0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a998f8ffdbe80bf754a93422e166156d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_798a88ba0b66e03b4b0cb572541ef136
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37832edd2cac8fc6fde6868905648a74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_553fddf2847b53c8e491c9624cc6ed33 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4178 |
| filingDate |
2011-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c125b2a86c66a0d6fab4f34f03304494
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97af9e04c5e4f39be18d0c54324fb448
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9530df6f8af10d91ab845701a1088ef4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_efc1738535c800019729614d4424cd5f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2b5b5a2c2d59424785113419f9fb55e |
| publicationDate |
2012-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2012002328-A1 |
| titleOfInvention |
Blood hdl level increasing agent or anti-arteriosclerotic agent |
| abstract |
Disclosed are: a novel PI polyamide which is useful for increasing a blood HDL level; and an anti-arteriosclerotic agent comprising the PI polyamide as an active ingredient. PI polyamide compounds (three types) which can control the expression of human ABCA1 gene are synthesized, and an anti-arteriosclerotic agent comprising any one of the PI polyamide conmpounds as an active ingredient can be produced. |
| priorityDate |
2010-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |